alcohol use disorder

Peptides

Beyond Weight Loss: GLP-1 Agonists Push Into Addiction Medicine and Vascular Repair

Semaglutide and liraglutide are being studied well past their metabolic origins. Early signals point to alcohol use disorder and diabetic blood-vessel protection — but the evidence is still uneven.

Medical Research

GLP-1 Drugs and Alcohol: A Small Trial Hints at a Delayed Drinking Effect

A secondary analysis of a placebo-controlled trial in patients with alcohol use disorder and obesity found exenatide lowered a blood marker of drinking — but only after months, not weeks.